NHS patients denied new lung cancer drug after another NICE deadlockCertain untreated lung cancer patients on England’s NHS will have to make do with older drugs after NICE Share XNHS patients denied new lung cancer drug after another NICE deadlockhttps://pharmaphorum.com/news/nice-deadlock/
Celltrion plans to launch a biosimilar each year for next decadeThere are plenty of pharma companies outlining their strategies for the new decade this week at the JP Share XCelltrion plans to launch a biosimilar each year for next decadehttps://pharmaphorum.com/news/celltrion-plans-to-launch-a-biosimilar-each-year-for-next-decade/
NICE rejects Astellas’ Xospata in AML, queries MSD’s Keytruda evidence in HNSCCNICE has been busy with announcements today, rejecting Astellas’ Xospata for a certain type of acute myeloid leukaemia Share XNICE rejects Astellas’ Xospata in AML, queries MSD’s Keytruda evidence in HNSCChttps://pharmaphorum.com/news/nice-rejects-astellas-xospata/
Akcea’s rare disease drug Waylivra way too pricey for NHS, says NICELess than a week into 2020 and NICE has provisionally ruled against NHS funding for another drug – Share XAkcea’s rare disease drug Waylivra way too pricey for NHS, says NICEhttps://pharmaphorum.com/news-market-access/akceas-rare-disease-drug-waylivra-way-too-pricey-for-nhs-says-nice/
NICE rejects Roche’s Tecentriq in new lung cancer useNICE has said in first draft guidance that Roche’s Tecentriq should not get regular NHS funding as a Share XNICE rejects Roche’s Tecentriq in new lung cancer usehttps://pharmaphorum.com/news/nice-rejects-roches-tecentriq-in-new-lung-cancer-use/
Novartis sets up free lottery for $2.1m SMA drug outside USNovartis is planning to give away 100 doses of its hugely expensive spinal muscular atrophy gene therapy Zolgensma Share XNovartis sets up free lottery for $2.1m SMA drug outside UShttps://pharmaphorum.com/news/novartis-to-give-away/
Scotland’s NHS to fund Roche’s Hemlibra in haemophilia ANHS patients in Scotland with haemophilia A are set to get access to Roche and Chugai’s prophylactic injection Share XScotland’s NHS to fund Roche’s Hemlibra in haemophilia Ahttps://pharmaphorum.com/news/scotlands-nhs-to-fund-roches-hemlibra-in-haemophilia-a/
Pharma prepares for Brexit as Tories win election majorityBoris Johnson’s Conservatives have won the UK’s general election with a large majority, leaving the industry preparing for Share XPharma prepares for Brexit as Tories win election majorityhttps://pharmaphorum.com/news/pharma-prepares-for-brexit-as-tories-win-election-majority/
UK’s NHS to fund Shionogi’s Mulpleo after backing from NICE and SMCShionogi’s Mulpleo for severely low levels of blood platelets caused by liver disease is to be made available Share XUK’s NHS to fund Shionogi’s Mulpleo after backing from NICE and SMChttps://pharmaphorum.com/news/uks-nhs-to-fund-shionogis-mulpleo-after-backing-from-nice-and-smc/
